Forms of fedratinib dihydrochloride
US11306062B2 · kind B2 · utility
0Cited by
3References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 29, 2020 |
| Grant date | Apr 19, 2022 |
| Priority date | — |
| Expiry date | Oct 29, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel forms of fedratinib dihydrochloride (diHCl) and processes for the preparation of the various forms. The present disclosure also relates to pharmaceutical compositions comprising the novel forms of fedratinib dihydrochloride and methods for treating disease using the forms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.